MarketCap
Facebook
X
Telegram
Pliant Therapeutics Shares | PLRX
Annual Shares Pliant Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.4 M | 60.5 M | 58.7 M | 42 M | 35.8 M | 35.4 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.4 M | 35.4 M | 49 M |
Quarterly Shares Pliant Therapeutics
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.4 M | 61.8 M | - | 61.4 M | 61.4 M | 61.2 M | 60.9 M | 60.7 M | 60.4 M | 60.2 M | 59.9 M | 59.7 M | 59.2 M | 56.1 M | 48.9 M | 46.8 M | 36.2 M | 36.1 M | 36.1 M | 35.9 M | 35.7 M | 35.6 M | 35.6 M | 35.4 M | 12.3 M | 1.9 M | 1.85 M | 1.71 M | 1.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.8 M | 1.56 M | 42.4 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
2.12 M | - | -6.63 % | $ 13.9 M |  USA |
 |
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Codexis
CDXS
|
87.1 M | $ 1.42 | 0.33 % | $ 124 M | USA |
 |
Synthetic Biologics
SYN
|
12.1 M | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
130 M | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
220 M | - | - | $ 866 M |  China |
 |
Corner Growth Acquisition Corp.
COOL
|
9.83 M | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
113 M | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
4.73 M | - | 1.35 % | $ 17.8 M | China |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
543 M | - | -13.47 % | $ 169 M | France |
 |
Cue Biopharma
CUE
|
94.7 M | $ 27.67 | 2.63 % | $ 2.62 B | USA |
 |
CureVac N.V.
CVAC
|
224 M | - | - | $ 867 M |  Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
9.34 B | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
229 M | - | - | $ 4.9 B |  Britain |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - |  Russia |
|
Galera Therapeutics
GRTX
|
98.5 M | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
54.9 B | - | -18.52 % | $ 27.3 M | Britain |
 |
Hepion Pharmaceuticals
HEPA
|
9.41 M | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
48.7 M | - | 1052.0 % | $ 415 M | USA |
 |
MorphoSys AG
MOR
|
34.3 M | - | 2.43 % | $ 254 M | Germany |
 |
Editas Medicine
EDIT
|
88.7 M | $ 3.08 | 0.33 % | $ 273 M | USA |
 |
Ardelyx
ARDX
|
241 M | $ 3.71 | 1.06 % | $ 894 M | USA |
 |
Affimed N.V.
AFMD
|
120 M | - | -34.95 % | $ 21.5 M | Germany |
 |
EyePoint Pharmaceuticals
EYPT
|
73.3 K | $ 4.57 | 0.21 % | $ 335 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
127 M | $ 23.66 | 0.04 % | $ 3.01 B | USA |
 |
Assembly Biosciences
ASMB
|
11.2 M | $ 36.13 | 4.38 % | $ 405 M | USA |
 |
Fate Therapeutics
FATE
|
119 M | $ 2.42 | 0.61 % | $ 287 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
38.2 M | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
22.6 M | - | - | $ 12.5 M |  Belgium |
 |
Adial Pharmaceuticals
ADIL
|
669 K | $ 6.66 | 5.38 % | $ 4.45 M | USA |
 |
Fortress Biotech
FBIO
|
27.9 M | $ 2.71 | 0.04 % | $ 75.6 M | USA |
 |
Generation Bio Co.
GBIO
|
66.6 M | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Anika Therapeutics
ANIK
|
14.3 M | $ 21.0 | 2.08 % | $ 301 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
338 M | - | - | $ 3.37 B | China |
 |
Axsome Therapeutics
AXSM
|
49.7 M | $ 208.35 | 0.16 % | $ 10.4 B | USA |
 |
GlycoMimetics
GLYC
|
27.6 M | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
28.8 M | $ 57.46 | 2.9 % | $ 1.65 B | USA |
 |
Aeterna Zentaris
AEZS
|
3.17 M | - | 5.93 % | $ 314 M | Canada |
 |
AVROBIO
AVRO
|
18.3 M | - | 1083.1 % | $ 745 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
192 M | $ 66.43 | 0.04 % | $ 12.7 B | USA |
 |
BeiGene, Ltd.
BGNE
|
1.42 B | - | 0.49 % | $ 251 B |  Cayman-islands |